Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Beijing Aosaikang Pharmaceutical Co., Ltd., commonly referred to as Aosaikang, is a prominent player in the pharmaceutical industry, headquartered in Beijing, China. Established in 2001, the company has made significant strides in the development and production of high-quality pharmaceutical products, particularly in the fields of cardiovascular and anti-infective medications.
With a strong operational presence across various regions in China and a commitment to innovation, Aosaikang has positioned itself as a leader in the market. The company’s core offerings include a diverse range of generic and proprietary drugs, distinguished by their efficacy and safety profiles. Notably, Aosaikang has achieved several industry certifications, underscoring its dedication to quality and compliance. As a result, it has garnered a solid reputation among healthcare professionals and patients alike, solidifying its status in the competitive pharmaceutical landscape.
-19 vs industry average
Beijing Aosaikang Pharmaceutical Co., Ltd.’s score of 23 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the most carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Beijing Aosaikang Pharmaceutical Co., Ltd. yet.
Beijing Aosaikang Pharmaceutical Co., Ltd., headquartered in CN, currently does not report any carbon emissions data, as indicated by the absence of specific figures. Consequently, there are no recorded emissions totals, including Scope 1, Scope 2, or Scope 3 emissions.
Additionally, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments towards reducing carbon emissions or addressing climate change.
As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Beijing Aosaikang to consider implementing measurable climate strategies and reduction initiatives to align with global climate goals.
No climate goals have been disclosed for Beijing Aosaikang Pharmaceutical Co., Ltd. yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more